COVID-19 >> New Drug Activity & VACCINE TRACKING!!

[cc]

https://www.zerohedge.com/covid-19/double-blind-ivermectin-study-reveals-covid-19-patients-recover-more-quickly-have-reduce">'For $1/Day'... Double-Blind Ivermectin Study Reveals COVID Patients Recover More Quickly, Are Less Infectious



A double-blind Israeli study has concluded that Ivermectin, an inexpensive anti-parasitic widely used since 1981, reduces both the duration and infectiousness of Covid-19, according to the Jerusalem Post.

The study, conducted by Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba Medical Center in Tel Hashomer, looked at some 89 eligible volunteers over the age of 18 who had tested positive for coronavirus, and were living in state-run Covid-19 hotels. After being divided into two groups, 50% received ivermectin, and 50% received a placebo. Each patient was given the drug for three days in a row, an hour before eating.



83% of participants were symptomatic at recruitment. 13.5% of patients had comorbidities of cardiovascular disease, diabetes, chronic respiratory disease, hypertension or cancer. The median age of the patients was 35, ranging from 20 to 71-years-old.



Results

Treatment was discontinued on the third day, and patients were monitored every two days thereafter. By day six, 72% of those treated with ivermectin tested negative for the virus, vs. 50% of those who received the placebo. Meanwhile, just 13% of ivermectin patients were able to infect others after six days compared to 50% of the placebo group - nearly four times as many.



Hospitalizations

Three patients in the placebo group were admitted to hospitals for respiratory symptoms, while one ivermectin patient was hospitalized for shortness of breath the day the study began - only to be discharged a day later and "sent back to the hotel in good condition," according to the study.



"Our study shows first and foremost that ivermectin has antiviral activity," said Schwartz, adding "It also shows that there is almost a 100% chance that a person will be noninfectious in four to six days, which could lead to shortening isolation time for these people. This could have a huge economic and social impact."



The study, which appeared on the MedRxiv preprint server and has not yet been peer-reviewed. That said, Schwartz pointed out that similar studies - 'though not all of them conducted to the same double-blind and placebo standards as his' - also showed favorable results for the drug.

[Anonymous]

Are we using Ivermectin in Canada to treat COVID patients?

[cc]

Not that I know of

[Anonymous]

Not that I know of

We should be using it.

[cc]

Agreed 100

[Anonymous]

Senator Lindsey Graham has caught COVID despite being fully vaccinated.



Graham revealed that he is experiencing "mild symptoms" after testing positive for COVID-19. He also praised the COVID-19 vaccine, saying he would probably feel much worse without it.

uh oh

[Anonymous]

Senator Lindsey Graham has caught COVID despite being fully vaccinated.



Graham revealed that he is experiencing "mild symptoms" after testing positive for COVID-19. He also praised the COVID-19 vaccine, saying he would probably feel much worse without it.

uh oh

There are more breakthrough cases with the Delta variant.

[Anonymous]

Canada is donating 82,000 doses of Astra Zeneca to Trinidad and Tobago.

[Anonymous]

The WHO doesn't want high income countries giving boosters while developing countries lack vaccines.



Ignoring WHO call, Germany, France to give COVID-19 vaccine boosters



PARIS/BERLIN, Aug 5 (Reuters) - Germany and France will go ahead with COVID-19 vaccine boosters from September, disregarding an appeal by the World Health Organisation (WHO) to hold off until more people are vaccinated across the globe.



The decision to press ahead with booster shots despite the strongest statement yet from the WHO highlights the challenge of dealing with a global pandemic while countries try to protect their own citizens from the more infectious Delta variant.



French President Emmanuel Macron said France was working on rolling out third COVID-19 vaccine doses to the elderly and vulnerable from September.



"A third dose will likely be necessary, not for everyone straightaway, but in any case for the most vulnerable and the most elderly," Macron said on his Instagram account.



Germany intends to give boosters to immunocompromised patients, the very elderly and nursing home residents from September, the health ministry said.



WHO chief Tedros Adhanom Ghebreyesus called on Wednesday for a halt to vaccine boosters until at least the end of September, saying it was unacceptable for rich countries to use more of the global vaccine supply.



High-income countries administered around 50 doses for every 100 people in May, and that number has since doubled, according to WHO. Low-income countries have only been able to administer 1.5 doses for every 100 people, due to lack of supplies.



"I understand the concern of all governments to protect their people from the Delta variant. But we cannot accept countries that have already used most of the global supply of vaccines using even more of it," Tedros said.



Germany rejected those accusations, saying it would also donate at least 30 million vaccine doses to poorer countries.



"We want to provide the vulnerable groups in Germany with a precautionary third vaccination and at the same time support the vaccination of as many people in the world as possible," the ministry said.



Macron's government is trying to step up France's vaccination programme as the country faces a fourth wave of the virus and street demonstrations in protest against the government's COVID policies.



France and Germany have so far given at least one dose of a COVID-19 vaccine to 64.5% and 62% of their respective populations, with 49% of the French and 53% of Germans fully-vaccinated.

https://www.reuters.com/world/europe/french-president-macron-third-covid-vaccine-doses-likely-elderly-vulnerable-2021-08-05/">https://www.reuters.com/world/europe/fr ... 021-08-05/">https://www.reuters.com/world/europe/french-president-macron-third-covid-vaccine-doses-likely-elderly-vulnerable-2021-08-05/

[Anonymous]

American Surgeon General Vivek Murthy has said he believes it is likely that a COVID-19 vaccine for children under 12 will be given emergency use authorization during the next school year.

[Anonymous]

The WHO doesn't want high income countries giving boosters while developing countries lack vaccines.



Ignoring WHO call, Germany, France to give COVID-19 vaccine boosters



PARIS/BERLIN, Aug 5 (Reuters) - Germany and France will go ahead with COVID-19 vaccine boosters from September, disregarding an appeal by the World Health Organisation (WHO) to hold off until more people are vaccinated across the globe.



The decision to press ahead with booster shots despite the strongest statement yet from the WHO highlights the challenge of dealing with a global pandemic while countries try to protect their own citizens from the more infectious Delta variant.



French President Emmanuel Macron said France was working on rolling out third COVID-19 vaccine doses to the elderly and vulnerable from September.



"A third dose will likely be necessary, not for everyone straightaway, but in any case for the most vulnerable and the most elderly," Macron said on his Instagram account.



Germany intends to give boosters to immunocompromised patients, the very elderly and nursing home residents from September, the health ministry said.



WHO chief Tedros Adhanom Ghebreyesus called on Wednesday for a halt to vaccine boosters until at least the end of September, saying it was unacceptable for rich countries to use more of the global vaccine supply.



High-income countries administered around 50 doses for every 100 people in May, and that number has since doubled, according to WHO. Low-income countries have only been able to administer 1.5 doses for every 100 people, due to lack of supplies.



"I understand the concern of all governments to protect their people from the Delta variant. But we cannot accept countries that have already used most of the global supply of vaccines using even more of it," Tedros said.



Germany rejected those accusations, saying it would also donate at least 30 million vaccine doses to poorer countries.



"We want to provide the vulnerable groups in Germany with a precautionary third vaccination and at the same time support the vaccination of as many people in the world as possible," the ministry said.



Macron's government is trying to step up France's vaccination programme as the country faces a fourth wave of the virus and street demonstrations in protest against the government's COVID policies.



France and Germany have so far given at least one dose of a COVID-19 vaccine to 64.5% and 62% of their respective populations, with 49% of the French and 53% of Germans fully-vaccinated.

https://www.reuters.com/world/europe/french-president-macron-third-covid-vaccine-doses-likely-elderly-vulnerable-2021-08-05/">https://www.reuters.com/world/europe/fr ... 021-08-05/">https://www.reuters.com/world/europe/french-president-macron-third-covid-vaccine-doses-likely-elderly-vulnerable-2021-08-05/

Who listens to the WHO.

[cc]

Who listens to the WHO.

Only fools.



Israel, and UK have already started boosters for elders vaccinated early without asking who .. and I'm guessin they will not stop doing so

[Anonymous]

Who listens to the WHO.

Only fools.



Israel, and UK have already started boosters for elders vaccinated early without asking who .. and I'm guessin they will not stop doing so

If a country has extra vaccines to give boosters, they will so to protect their vulnerable populations..



The WHO's opinions are irrelevant.

[cc]

https://thespectator.info/2021/08/05/here-we-go-moderna-calls-for-3rd-shot-of-vaccine-to-protect-against-new-strains/">Moderna announced this week that due to the new strains of the coronavirus they are recommending a third shot before winter.



Vaccine developers at Moderna "are looking forward towards our vision of a single dose annual booster that provides protection against COVID-19, flu and [respiratory syncytial virus] for adults. ... We believe this is just the beginning," CEO Stephane Bancel said.



The company has conducted studies to determine the benefits of administering a third "booster" shot of its two-dose vaccine to protect against the highly contagious delta variant that accounts for a majority of COVID-19 cases, as well as any future strains of the virus that develop.



Moderna's Phase 2 trial of a 50-microgram booster dose generated a strong immune response against the delta, gamma, and beta variants — all of which seem to spread more easily and quickly than other variants, which could lead to more COVID-19 outbreaks. The third dose produced an antibody response nearly as strong as the response generated in previously unvaccinated people who received the first two doses of the vaccine.

[Odinson]

Yes...



Moderna is recommending another Cha-Ching moment.